Spire Healthcare Group PLC

Remuneration Information • Mar 31, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1630B

Spire Healthcare Group PLC

31 March 2017

31 March 2017

Spire Healthcare Group plc

Grant of 2017 Long Term Incentive Plan awards

Spire Healthcare Group plc (the "Company") announces that, on 30 March 2017, performance share awards (the "Awards") were granted over the Company's ordinary shares in the form of nil cost options to the following Executive Directors in the Company, under the rules of the Spire Healthcare Group plc Long Term Incentive Plan.

Name                         Maximum number of shares under Awards

Simon Gordon           223,146

Andrew White            221,628

The number of shares set out above is the maximum number which may vest under the Awards following the cessation of the performance period. The actual number of shares which vest will depend on the extent to which the following performance conditions have been satisfied.

The performance conditions applicable to the Awards will be based as follows:

·    35% on relative total shareholder return (TSR) performance;

·    35% on adjusted earnings per share (EPS) performance; and

·    30% on two Operational Excellence measures.

Full details of these performance conditions will be disclosed in the 2016 Directors' Remuneration Report which will be published in April.

The share price used to determine the number of shares under the Awards was £3.294 being the average of the middle market quotation at close of business over the last five dealing days ending on 29 March 2017.

The transaction place is London.

Name of contact and telephone number for queries:

Philip Davies                                                 020 7427 9092

Deputy Company Secretary

The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

a)	Name	Simon Gordon
2	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Spire Healthcare Group plc
b)	LEI	213800IBJPW3SE2RA350
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1 pence each GB00BNLPYF73
b)	Nature of the transaction	Grant of performance share awards under the Company's Long Term Incentive Plan
c)	Price(s) and volume(s)	Price(s)	Volume(s)
Nil	223,146
d)	Aggregated information - Aggregated volume - Price	As above
e)	Date of the transaction	2017-03-30
f)	Place of the transaction	XLON

a)	Name	Andrew White
2	Reason for the notification
a)	Position/status	Executive Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Spire Healthcare Group plc
b)	LEI	213800IBJPW3SE2RA350
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1 pence each GB00BNLPYF73
b)	Nature of the transaction	Grant of performance share awards under the Company's Long Term Incentive Plan
c)	Price(s) and volume(s)	Price(s)	Volume(s)
Nil	221,628
d)	Aggregated information - Aggregated volume - Price	As above
e)	Date of the transaction	2017-03-30
f)	Place of the transaction	XLON

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHGIGDXLSXBGRB